107 results
Page 4 of 6
6-K
EX-99.1
bawde9pb
30 Sep 13
Live Filing
12:00am
6-K
p8c43d2 xelnb
18 Jul 13
Current report (foreign)
12:00am
6-K
EX-99
s7jh gicravbc
30 May 13
TEVA ANNOUNCES FDA ACCEPTANCE OF sNDA FOR A HIGHER CONCENTRATION DOSE OF COPAXONE®GIVEN THREE TIMES A WEEK
12:00am
6-K
EX-99.1
suy6ipahx2asdwn6 58
25 Apr 13
Live Filing
12:00am
6-K
EX-99.1
vijj82jg6
8 Apr 13
Teva-Handok Names Yoo Suk Hong as Chief Executive Officer
12:00am
6-K
EX-99.1
b2v6e2w8
17 Dec 12
Teva Enters Agreement with Handok to Establish Business Venture with Significant Presence in Korean Pharmaceutical Market
12:00am
6-K
rg4o6a
5 Dec 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
424B5
kfsj1z4ozlbb
8 Nov 11
Prospectus supplement for primary offering
12:00am
424B5
bgi9b773hv dg8vyr1d2
7 Nov 11
Prospectus supplement for primary offering
12:00am
6-K
e9u9r2tx6mrw40byg
24 Mar 11
the Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership
12:00am
424B5
m3mjznp75wymr62 mmw
17 Mar 11
Prospectus supplement for primary offering
12:00am
424B5
wcvyq9uphx868w0k33dz
16 Mar 11
Prospectus supplement for primary offering
12:00am
424B5
l4b6f4 awc33mluz
16 Jun 10
Prospectus supplement for primary offering
12:00am
F-3ASR
0bubls2msc45 rtjn
4 Dec 08
Automatic shelf registration (foreign)
12:00am